Agilent Technologies Inc. (A)
Wall Street's Insights Into Key Metrics Ahead of Agilent (A) Q3 Earnings
Beyond analysts' top -and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2024.
Analysts Estimate Agilent Technologies (A) to Report a Decline in Earnings: What to Look Out for
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
Agilent (A) unveils its new ProteoAnalyzer system in a bid to strengthen its Diagnostics and Genomics Group segment.
Agilent to buy contract drug manufacturer Biovectra for $925 million
Agilent Technologies said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
History Says These Could Be 3 of the Best Healthcare Stocks to Own in the Second Half of 2024
Intuitive Surgical's game-changing robotic surgical systems should continue fueling considerable growth for the business. UnitedHealth is in an excellent position to benefit from the health insurance industry's long-term growth.
Why Is Agilent (A) Down 0.5% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
New Strong Sell Stocks for June 7th
A, CAR and BGS have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2024.
Agilent (A) Boosts Reach to Lab Researchers With New Devices
Agilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell.
Agilent Technologies, Inc. (A) Jefferies 2024 Global Healthcare Conference (Transcript)
Agilent Technologies, Inc. (NYSE:A ) Jefferies 2024 Global Healthcare Conference June 5, 2024 8:30 AM ET Company Participants Robert McMahon - Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Tycho Peterson All right, we're good to go. Good morning, everyone.
Investing in Agilent (A)? Don't Miss Assessing Its International Revenue Trends
Examine the evolution of Agilent's (A) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Agilent (A) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
Agilent's (A) fiscal second-quarter results reflect weak momentum across all end markets.
Agilent Technologies, Inc. (A) Q2 2024 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q2 2024 Results Conference Call May 29, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Padraig McDonnell - President & Chief Executive Officer Bob McMahon - Senior Vice President & Chief Financial Officer Phil Binns - President of Agilent Life Sciences & Applied Markets Group Simon May - President of the Agilent Diagnostics and Genomics Group Angelica Riemann - President of Agilent CrossLab Group Conference Call Participants Matt Sykes - Goldman Sachs Jack Meehan - Nephron Research Patrick Donnelly - Citi Vijay Kumar - Evercore ISI Dan Brennan - TD Cowen Rachel Vatnsdal - JPMorgan Doug Schenkel - Wolfe Research Michael Ryskin - Bank of America Dan Arias - Stifel Josh Waldman - Cleeland Research Catherine Schulte - Baird Paul Knight - KeyBanc Operator Ladies and gentlemen, welcome to the Agilent Technologies Q2 2024 Earnings Call. My name is Regina, and I will be coordinating your call today.
